Murayama Toshinori

Affiliation and department：
Job title：部長/教授

Research field (1)： Medical equipment testing

Research theme for competitive and other funds (6)：

2019 - 2022 Development of new therapeutoc strategy for high-risk chemotherapy-refractory neuroblastoma
2016 - 2019 Establishment of therapeutic strategy for advanced gastrointestinal cancer with targeted alpha therapy
2013 - 2016 A Comprehensive Research aiming at an Integration of Various Ethical Guidelines involving Medical Research -Protection of Study Participants and Public Welfare-
2009 - 2011 Risk-based protection of participants in un-notified clinical trials No-fault Compensation & Informed Consent-
2007 - 2008 The Consolidation of Ethical Infrastructures Supporting Clinical Trials for the Development of Advanced Medicine Technology

Show all

Papers (110)：

Anri Inaki, Atsushi Mizokami, Hiroshi Wakabayashi, Kouji Izumi, Yoshifumi Kadono, Tadashi Toyama, Shizuko Takahara, Toshinori Murayama, Seigo Kinuya. Evaluation of 68Ga-PSMA-11 PET/CT: a Phase 1 clinical study in Japanese patients with primary, recurrent, or suspected recurrent prostate cancer. Annals of nuclear medicine. 2024
Ko Aiga, Mitsuhiro Kometani, Shigehiro Karashima, Seigo Konishi, Takuya Higashitani, Daisuke Aono, Xurong Mai, Mikiya Usukura, Takahiro Asano, Ayako Wakayama, et al. A clinical assessment of portable point-of-care testing for quick cortisol assay during adrenal vein sampling. Scientific reports. 2023. 13. 1. 22429-22429
于佳, 今井康人, 野村章洋, 米田隆, 村山敏典. 日本国内での新型コロナウイルス感染症のパイロット観察研究における電子同意書の使用(Use of Electronic Consent Forms in an Observational Pilot Study of Coronavirus Disease in Japan). 薬理と治療. 2022. 50. Suppl.2. s154-s165
Hiroshi Wakabayashi, Anri Inaki, Kenichi Yoshimura, Toshinori Murayama, Yasuhito Imai, Tetsuya Higuchi, Megumi Jinguji, Tohru Shiga, Seigo Kinuya. Author Correction: A phase I clinical trial for [131I]meta-iodobenzylguanidine therapy in patients with refractory pheochromocytoma and paraganglioma. Scientific Reports. 2022. 12. 1. 1347-1347
Rie Kuroda, Hiroshi Wakabayashi, Raita Araki, Anri Inaki, Ryosei Nishimura, Yasuhiro Ikawa, Kenichi Yoshimura, Toshinori Murayama, Yasuhito Imai, Tatsuyoshi Funasaka, et al. Phase I/II clinical trial of high-dose [131I] meta-iodobenzylguanidine therapy for high-risk neuroblastoma preceding single myeloablative chemotherapy and haematopoietic stem cell transplantation. European journal of nuclear medicine and molecular imaging. 2022. 49. 5. 1574-1583

ｍore...

MISC (207)：

溝上敦, 稲木杏吏, 泉浩二, 村山敏典, 重原一慶, 野原隆弘, 角野佳史, 若林大志, 絹谷清剛. 前立腺がん患者を対象とした68Ga-PSMA-11の第I相試験. 日本癌治療学会学術集会抄録集. 2022. 60回. 優秀O24-4
村山敏典. また改正?!臨床研究の分類に応じた留意点. 日本整形外科学会雑誌. 2022. 96. 7. 529-541
今井康人, 杉本修治, 山崎章子, 大嶋三郎, 古川仭, 村山敏典, 金子周一. 人工知能(AI)によるHAT(Health Age Trust)システム構築における介護スタッフの業務効率化向上に関するアンケート調査研究. 日本未病学会雑誌. 2022. 28. 1. 31-42
今井康人, 杉本修治, 山崎章子, 大嶋三郎, 古川仭, 村山敏典, 金子周一. 人工知能(AI)によるHAT(Health Age Trust)システム構築における介護スタッフの業務効率化向上に関するアンケート調査研究. 日本未病学会雑誌. 2022. 28. 1. 31-42
村山敏典. また改正?! 臨床研究の分類に応じた留意点. 日本整形外科学会雑誌. 2021. 95. 2. S394-S394

ｍore...

Professional career (1)：

京都大学博士(医学) (京都大学)

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page